CORONARY HEART DISEASE (CHD) is the leading cause of death in the United States, accounting for approximately 490,000 deaths in 1993. 1 Three leading manifestations of CHD include angina pectoris, myocardial infarction (MI), and sudden death. Angina pectoris, as represented by Diagnosis Related Groups (DRGs) 132 (atherosclerosis with complications and comorbidities) and 140 (angina pectoris), was the ninth leading discharge diagnosis for Texas Medicare patients in 1996, accounting for 13,586 discharges or 2.1% of all Medicare discharges in 1993.
the aspirin group (160 mg/day). 4 In the unstable angina pectoris/non-Q wave MI study, the RISC trial of a 75 mg daily aspirin dose showed a 61% reduction in MI and death at 90 days follow-up. 5 The Texas Medical Foundation (TMF), the Quality Improvement Organization (QIO) for Texas, developed a Health Care Quality Improvement Program (HCQIP) 6 project to improve aspirin prophylaxis for Medicare patients admitted with cardiac-related acute chest pain/angina. An earlier pilot project at an acute-care facility that implemented a clinical pathway resulted in a 45.3% (P < .001) improvement in aspirin administration. This was an expanded, follow-up HCQIP project to improve care for Medicare patients with cardiacrelated acute chest pain/angina at additional acute-care facilities.
METHODS
Ten acute-care facilities, identified from Health Care Financing Administration (HCFA) claims data, agreed to participate in the project. Selection criteria included having 20 or more DRG 132 or 140 discharges in 1 year, with average lengths of stay of ≥5 days and with significant variation in lengths of stay. Three facilities' characteristics were similar to those of the pilot project facility (urban, nonteaching, non-public hospitals with an average daily census <51). The other seven acute-care facilities ranged from small rural non-teaching hospitals with an average daily census of <51 to large urban teaching hospitals with an average daily census >200.
The 10 facilities were invited to attend one of two group meetings conducted by the TMF.
At the meetings, the TMF discussed the concept and process for collaborating in an HCQIP project, provided information on continuous quality improvement (CQI) techniques necessary to identify opportunities for improvement, and provided education on the development of clinical pathways. In addition, the TMF reviewed the clinical pathway developed in the pilot project and the results based on its implementation.
Each collaborator was asked to evaluate its processes of care and develop and implement process of care interventions based on identified opportunities for improvement as part of an improvement plan. These improvements could include clinical pathways, standing orders, physician education, etc. While each facility was expected to develop an improvement plan based on its identified improvement opportunities, the TMF requested that each facility specifically include interventions to improve aspirin administration (aspirin administration during hospital stay, aspirin administration at discharge, and average time from arrival to administration of aspirin) in its plan. Previous project experience indicated that collaborating facilities implement facilityspecific process changes that make use of a uniform clinical pathway impractical. The TMF informed the facilities that it would collect baseline and follow-up data from a sample of Medicare patients after improvement plans had been done and in place for at least 6 months.
The TMF did a retrospective chart audit, collecting facility-specific baseline and followup measurements from a random sample of 35 medical records, if ≥35 cases were available, The retrospective chart audit used a data abstraction instrument and instructions that included the aspirin administration quality indicators and incorporated facility-specific indicators based on facility-improvement plans. The Chi-square test was used to determine significance of changes for aspirin administration, and the t test was used for the analysis of time from arrival to aspirin administration.
RESULTS
Of the Medicare patients included in the project, 61.1% of the baseline and 60.1% of the remeasurement patients were female, and the average age was 74.6 years for baseline and 75.2 years for remeasurement; 107 of the baseline and 108 of the remeasurement patients were taking aspirin on admission. Aspirin was contraindicated for 85 of the baseline and 67 of the remeasurement patients.
Results for individual facilities and all facilities are contained in the Table. Based on identified process of care opportunities, all 10 collaborating acute-care facilities identified process of care inter ventions and implemented improvement plans. Eight improvement plans (A, B, C, D, G, H, I, and J) incorporated clinical pathways of care. Five plans (A, B, E, F, and H) included a physician checklist for medications, three as a part of clinical pathways (A, B, and H). Nine of the plans (A, B, C, D, E, F, H, I, and J) addressed administration of aspirin, including instructions for timing of aspirin administration either in the emergency department (C and E) or within the first hour (A, F, H, I, and J), or on admission (B and D), and four specified type of aspirin to be given (A, E, F, and H). Two plans (B and J) addressed physician education. In one of these two plans (B), education focused on emergency department physicians and stressed the importance of aspirin administration in the emergency department. At this facility, a large public teaching hospital, the director of medical education also makes presentations on quality improvement initiatives, highlighting improvements and shortcomings. The other plan emphasized education about anticoagulation and thrombolytic therapy and did not specifically address aspirin administration.
Data indicate that all collaborating facilities improved performance for at least one of the quality indicators. Seven facilities improved aspirin administration during hospital stay (A, B, C, D, E, F, and G) and at discharge (A, B, C, D, E, I, and J), and eight facilities decreased average time from arrival to administration of aspirin (A, B, C, D, E, H, I, and J) from baseline to remeasurement. Of the 10 facilities, five (A, B, C, D, and E) showed consistent improvement on all three of the quality indicators. Of these five facilities, four (A, B, C, and D) implemented clinical pathways, all of which addressed timing of aspirin administration and two of which incorporated physician medication checklists (A and B). The fifth facility (E) set up a physician medication checklist.
The two top performing facilities' (A and B) interventions consisted of clinical pathways that incorporated physician medication checklists and addressed timing of aspirin administration. One of these two facilities provided education to emergency department physicians on the importance of aspirin administration in the emergency room. Each of these facilities showed large but statistically non-significant improvement in administration of aspirin during hospital stay and at discharge. Average time from arrival to administration of aspirin decreased at both facilities and was statistically significant for one (B) (-11.29 hours, P < .05) (Table) . Small sample size for each facility may have contributed to non-significant results.
Remeasurement data at three facilities indicate decreased aspirin administration during hospital stay (H, I, and J) and on discharge (F, G, and H). Average time from arrival to aspirin administration increased at two facilities (F and G). One facility (G), with decreased aspirin administration at discharge, increased time from arrival to aspirin administration and limited improvement in aspirin administration during hospital stay, implemented a clinical pathway that specified only consideration of anticoagulation, and did not directly address either aspirin administration or timing of administration.
No identifiable pattern emerged between type of facility and degree of improvement. Of the two facilities (A and B) with the most significant improvement, one was a small rural non-teaching hospital (A), and the other was a large urban teaching hospital (B). Similarly, the two facilities (F and G) with the least improvement were large urban facilities of which one was a teaching hospital (H).
Aggregate data for the 10 collaborating facilities indicated statistically significant overall improvement for each of the quality indicators: the rate of administration of aspirin during hospital stay increased 10.8% (P < .005); the rate of aspirin on discharge increased 11.7% (P < .05); the average time from arrival to aspirin administration decreased 2.9 hours (P < .02) (Table) .
DISCUSSION
Currently, most TMF HCQIP projects use process measures. Jencks 7 has defined when it is appropriate to use process indicators versus outcome indicators. Process indicators are appropriate "when science clearly identifies critical elements of care that are well documented, and when outcomes are delayed," while outcome indicators are appropriate "when clinical outcomes can largely be controlled but the science base for individual elements is weak and documentation is poor or difficult to summarize." Because TMF projects seek to improve care through adherence to practice guidelines that are well-documented in the literature and represent clinical consensus, TMF typically uses process indicators in its quality improvement projects.
In the quality improvement projects done by TMF under HCQIP, inter ventions are expected to be implemented by all collaborating facilities that have an identified opportunity for improvement in the quality indicators used in the project. Quality improvement projects usually do not use a case/control design, where measurements are made in comparable facilities that did not participate in the project and implement process improvements. Consequently, determining if improvements at the collaborating facilities actually resulted from the interventions implemented in the project is difficult. 7 As noted in the results section, one of the collaborating facilities did not specifically address the common quality indicators focused on improving aspirin administration despite implementing a clinical pathway, and the resulting poor performance may be attributed to this. Facility inter ventions should be focused at improving the processes of care that will lead to improved quality of care for Medicare patients who are being treated for a specific condition and that may benefit other patients admitted to the facility for similar treatment.
Overall, the aggregate data suggest that the combined impact of collaborator-implemented interventions in this HCQIP project significantly improved the processes of care for Medicare patients admitted for cardiacrelated acute chest pain/angina at these acutecare facilities. While two of the facilities attained large improvements through their process of care changes, individual facility data indicate, nevertheless, that opportunities for further improving processes of care remain.
The most significant facility results appear to be linked to process-of-care interventions that included structural changes. Ensuring aspirin administration in the emergency department appears to have been more effectively accomplished when clinical pathways incorporated physician medication checklists and time from arrival to administration was impacted most when interventions specifically addressed timing. Likewise, including aspirin administration on physician discharge orders appears to have reduced reliance on physician recall for appropriate medications, thereby improving aspirin administration on discharge.
Discussion with representatives from one of the two facilities with the most demonstrated improvement and a review of its improvement plan indicated that its director of medical education was directly involved in its quality improvement process. This individual reinforces process changes at medical staff meetings through presentations on present status, desired outcomes, and interventions to reach objectives. Increased administration of aspirin during hospital stay and the reduction in average time to aspirin administration for this facility was affected by emergency room physicians initiating aspirin treatment rather than waiting until a patient is admitted to the floor. Similarly, increased administration of aspirin on discharge was affected by including it on physician discharge orders so that the physician only has to check a box to indicate if the patient should be discharged on aspirin.
Failure to collect baseline data before implementation of facility improvement plans may have contributed to the limited improvement realized at some of the facilities. The variation in individual facility results for the common indicators-aspirin administration during hospital stay and on discharge and timing from arrival to initial administration-was significant and may have been due to this fact. This variation in results may also be attributed to different levels of sophistication with CQI processes at the individual facilities. While overall improvement was realized, the results indicate that each of the facilities can still make additional improvements.
The results also suggest that these acutecare facilities were able to improve (and have opportunity to further improve) their processes of care by adapting a quality improvement process (a clinical pathway) from another facility and through the application of CQI techniques to their internal processes of care to promote internal process improvement. Whether the results of this project can be attributed to these inter ventions or to other causes is indeterminate from the design of this project. 8 They also suggest that collaboration with a QIO may have contributed to the successful process-of-care improvements.
